Q3 2017 Holdings
Filed 2017-11-13 | 91 holdings | $160.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| RA Pharmaceuticals Inc | COM | 74933V108 | $1.5K | 102,150 | 0.0% |
| Mimedx Group Inc(MDXG) | COM | 602496101 | $1.8K | 150,000 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $1.9K | 118,116 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $2.4K | 117,647 | 0.0% |
| Proteon Therapeutics Inc | COM | 74371L109 | $2.5K | 1,224,899 | 0.0% |
| Akari Therapeutics PLC | SPONSORED ADR | 00972G108 | $2.7K | 433,551 | 0.0% |
| Bioscrip Inc(BIOSEUR) | COM | 09069N108 | $3.0K | 1,107,166 | 0.0% |
| Obalon Therapeutics Inc | COM | 67424L100 | $3.3K | 351,284 | 0.0% |
| Aralez Pharmaceuticals Inc | COM | 03852X100 | $3.8K | 1,644,583 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $4.2K | 68,000 | 0.0% |
| Sierra Oncology Inc | COM | 82640U107 | $4.3K | 2,800,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $4.5K | 817,435 | 0.0% |
| Steadymed LTD | SHS | M84920103 | $4.8K | 1,418,787 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $5.4K | 1,221,775 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $5.9K | 190,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $6.2K | 165,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $6.2K | 325,000 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $6.2K | 400,685 | 0.0% |
| Mckesson Corp(MCK)Call | COM | 58155Q103 | $6.6K | 43,200 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $7.2K | 1,052,000 | 0.0% |
| Nucana PLC | SPONSORED ADR | 67022C106 | $7.8K | 424,950 | 0.0% |
| Clementia Pharmaceuticals in | COM | 185575107 | $7.8K | 462,387 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $8.0K | 1,355,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $8.1K | 582,000 | 0.0% |
| Alimera Sciences Inc | COM | 016259103 | $8.2K | 6,052,935 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $8.4K | 900,000 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $9.8K | 653,000 | 0.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $9.9K | 102,000 | 0.0% |
| Allscripts Healthcare Solutn | NOTE 1.250% 7/0 | 01988PAD0 | $10.3K | $9,671,000 | 0.0% |
| Invuity Inc | COM NEW | 46187J205 | $10.5K | 1,177,229 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $10.8K | 933,100 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $12.0K | 522,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $12.6K | 580,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $13.2K | 130,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $13.3K | 700,526 | 0.0% |
| Aegerion Pharmaceuticals Inc | NOTE 2.000% 8/1 | 00767EAB8 | $13.4K | $16,600,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $14.1K | 203,000 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $14.4K | 1,568,921 | 0.0% |
| Advanced Accelerator Applic | SPONSORED ADS | 00790T100 | $14.7K | 218,000 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $15.6K | 169,000 | 0.0% |
| Amag Pharmaceuticals Inc | NOTE 3.250% 6/0 | 00163UAD8 | $15.7K | $16,250,000 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $15.9K | 945,710 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $16.1K | 672,994 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $16.1K | 298,545 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $16.2K | 850,143 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $17.1K | 1,901,685 | 0.0% |
| AAC Hldgs Inc(AACH) | COM | 000307108 | $17.2K | 1,733,276 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $17.4K | 951,629 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $17.7K | 258,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $18.7K | 1,268,945 | 0.0% |